Aura Biosciences, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-5.1M | $-5.2M | $71.0K | $185.0K |
| Jun 2021 | $-6.5M | $-7.2M | $662.0K | — |
| Sep 2021 | $-8.7M | $-9.3M | $573.0K | — |
| Mar 2022 | $-15.2M | $-15.8M | $599.0K | $1.6M |
| Jun 2022 | $-10.6M | $-10.7M | $74.0K | — |
| Sep 2022 | $-10.8M | $-10.8M | $63.0K | — |
| Mar 2023 | $-16.4M | $-16.5M | $109.0K | $1.9M |
| Jun 2023 | $-14.6M | $-14.8M | $193.0K | — |
| Sep 2023 | $-15.4M | $-15.5M | $90.0K | — |
| Mar 2024 | $-24.5M | $-24.5M | $88.0K | $2.9M |
| Jun 2024 | $-16.1M | $-16.7M | $525.0K | — |
| Sep 2024 | $-15.3M | $-15.6M | $341.0K | — |
| Mar 2025 | $-23.4M | $-23.5M | $187.0K | $3.5M |
| Jun 2025 | $-20.8M | $-20.8M | $39.0K | — |
| Sep 2025 | $-20.1M | $-20.2M | $45.0K | — |
| Mar 2026 | $-29.9M | $-30.0M | $102.0K | $3.8M |
| Jun 2026 | $-32.5M | $-32.5M | $21.0K | — |